Related Experiment Videos
Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques
British Journal of Cancer
|November 17, 2001
Summary
New antiangiogenic and antivascular agents offer novel cancer treatments, potentially overcoming resistance issues. Reliable imaging techniques are crucial for assessing tumor angiogenesis and guiding these therapies in clinical trials.
Area of Science:
- Oncology
- Vascular Biology
- Medical Imaging
Background:
- Tumor growth beyond 1-2 mm³ necessitates new blood vessel formation (angiogenesis).
- Tumor vasculature exhibits structural and functional differences from normal tissue.
- Antiangiogenic and antivascular agents present alternative cancer treatment strategies, addressing resistance to conventional therapies.
Discussion:
- Emerging imaging techniques are vital for evaluating the efficacy of antiangiogenic and antivascular therapies.
- Assessing tumor angiogenesis in vivo is critical for clinical translation.
- These novel agents aim to inhibit tumor neovascularization, impacting tumor survival and proliferation.
Key Insights:
- Tumor neovascularization is essential for tumor growth and survival.
- Antiangiogenic and antivascular therapies target tumor vasculature.
- Reliable in vivo assessment of angiogenesis is needed for clinical application.
Outlook:
- Clinical trials are underway for antiangiogenic and antivascular therapies.
- Advancements in imaging are expected to facilitate the clinical adoption of these treatments.
- Successful implementation requires robust methods to monitor treatment response and assess angiogenesis.